|
1
|
Ehrlich P: Contributions to the Theory and
Practice of Histolo-gical staining. PhD Thesis. University of
Leibzig, Leibzig, 1878.
|
|
2
|
Varricchi G and Marone G: Mast cells:
Fascinating but still elusive after 140 years from their discovery.
Int J Mol Sci. 21(464)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Theoharides TC, Valent P and Akin C: Mast
cells, mastocytosis and related disorders. N Engl J Med.
373:163–172. 2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Metcalfe DD and Akin C: Mastocytosis:
Molecular mechanisms and clinical disease heterogeneity. Leuk Res.
25:577–582. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hartmann K and Henz BM: Mastocytosis:
Recent advances in defining the disease. Br J Dermatol.
144:682–695. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Akin C: Mast cell activation syndromes. J
Allergy Clin Immunol. 140:349–355. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Khokhar D and Akin C: Mast cell
activation. When the whole is greater than the sum of its parts.
Med Clin North Am. 104:177–187. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Valent P, Akin C, Gleixner KV, Sperr WR,
Reiter A, Arock M and Triggiani M: Multidisciplinary challenges in
mastocytosis and how to address with personalized medicine
approaches. Int J Mol Sci. 20(2976)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pardanani A: Annual Clinical Updates in
Hematological Malignancies: Systemic mastocytosis in adults: 2019
update on diagnosis, risk stratification and management. Am J
Hematol. 94:363–377. 2019.
|
|
10
|
Bonadonna P, Zanotti R, Pagani M, Caruso
B, Perbellini O, Colarossi S, Olivieri E, Dama A, Schiappoli M,
Senna G, et al: How much specific is the association between
hymenoptera venom allergy and mastocytosis? Allergy. 64:1379–1382.
2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Nilsson G and Dahlin JS: New insights into
the origin of mast cells. Allergy. 74:844–845. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Weiler CR, Austen KF, Akin C, Barkoff MS,
Bernstein JA, Bonadonna P, Butterfield JH, Carter M, Fox CC,
Maitland A, et al: AAAAI Mast Cell Disorders Committee Work Group
Report: Mast cell activation syndrome (MCAS) diagnosis and
management. J Allergy Clin Immunol. 144:883–896. 2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Valent P, Akin C, Bonadonna P, Hartmann K,
Brockow K, Niedoszytko M, Nedoszytko B, Siebenhaar F, Sperr WR,
Oude Elberink JN, et al: Proposed diagnostic algorithm for patients
with suspected mast cell activation syndrome. J Allergy Clin
Immunol Pract. 7:1125–1133.e1. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Picard M, Giavina-Bianchi P, Mezzano V and
Castells M: Expanding spectrum of mast cell activation disorders:
Monoclonal and idiopathic mast cell activation syndromes. Clin
Ther. 35:548–562. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Khoury P and Lyons JJ: Mast cell
activation in the context of elevated basal serum tryptase:
Genetics and presentations. Curr Allergy Asthma Rep.
19(55)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Schwartz LB: Diagnostic value of tryptase
in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am.
26:451–463. 2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ahmed F, Fried AJ, Spielman S, Secor W and
MacGinnitie AJ: Utility of measuring tryptase levels in children
and young adults. Ann Allergy Asthma Immunol. 123:398–399.
2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Leru PM: Eosinophilia and
hypereosinophilic disorders - update on etiopathogeny,
classification and clinical approach. Rom J Intern Med. 53:289–295.
2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Leru PM: Eosinophilic disorders:
Evaluation of current classification and diagnostic criteria,
proposal of a practical diagnostic algorithm. Clin Transl Allergy.
9(36)2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Galdiero MR, Varricchi G, Seaf M and
Marone G, Levi-Schaffer F and Marone G: Bidirectional mast
cell-eosinophil interactions in inflammatory disorders and cancer.
Front Med (Lausanne). 4(103)2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Kluin-Nelemans HC, Reiter A, Illerhaus A,
van Anrooij B, Hartmann K, Span LF, Gorska A, Niedoszytko M, Lange
M, et al: Prognostic impact of eosinophils in mastocytosis:
Analysis of 2350 patients collected in the ECNM Registry. Leukemia.
34:1090–1101. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Manea I, Ailenei E, Candrea E, Dima D and
Deleanu D: Diagnostic challenge in a patient with severe pruritic
rash. Ann Allergy Asthma Immunol. 114:65–67. 2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Grigore O, Mihailescu AI, Solomon I, Boda
D and Caruntu C: Role of stress in modulation of skin neurogenic
inflammation. Exp Ther Med. 17:997–1003. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Solomon I, Ilie MA, Draghici C, Voiculescu
VM, Căruntu C, Boda D and Zurac S: The impact of lifestyle factors
on evolution of atopic dermatitis: An alternative approach. Exp
Ther Med. 17:1078–1084. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Leru PM and Deleanu DM: Romanian
allergology in the actual European context. Rom J Intern Med.
53:111–117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Castells M and Butterfield J: Mast cell
activation syndrome and mastocytosis: Initial treatment options and
long-term management. J Allergy Clin Immunol Pract. 7:1097–1106.
2019.PubMed/NCBI View Article : Google Scholar
|
